Tomoko Hata¹, Masafumi Taniwaki², Toru Sakura³, Toshihiro Miyamoto⁴, Kensuke Usuki⁵, Shinji Tetsuo⁶, Ei Leen Liew⁷, Kiyohiko Hatake⁸ (1.Dept. of Hematology, Nagasaki University Hospital, Nagasaki, Japan, 2.Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.Leukemia Research Center, Saiseikai Maebashi Hospital, Gunma, Japan, 4.Department of Medicine and Biosystemic Science, Kyushu University, Fukuoka, Japan, 5.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan, 6.Department of Clinical Management, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan, 7.Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan, 8.Department of Hematology, International University of Health and Welfare, Tokyo)

Jo Ishizawa¹, Takenobu Nii², Ran Zhao¹, Lauren Heese¹, Yuki Nishida¹, Gautam Borthakur¹, Kensuke Kojima^1,3, Joshua Allen⁴, Varun Prabhu⁴, R Eric Davis⁵, Michael Andreeff¹ (1.Dept. of Leukemia, UT MD Anderson, Houston, USA, 2.Kyushu Univ., Kyushu, Japan, 3.Div. Hematol., Resp Med, and Oncol., Saga Univ., Saga, Japan, 4.Oncoceutics, Inc., Philadelphia, USA, 5.Dept. of Lymphoma/Myeloma, UT MD Anderson, Houston, USA)

Tomoko Hyoda¹, Yuya Kunisaki², Kentaro Hosokawa², Tsuyoshi Hirota³, Kazuhito Gotoh⁴, Daiki Setoyama⁴, Dongchon Kang⁴, Fumio Arai² (1.Health Science, Kyushu Univ., Fukuoka, Japan, 2.Stem Cell Biology, Kyushu Univ., Fukuoka, Japan, 3.Transformative Bio-Molecules, Nagoya Univ., Japan, 4.Clinical Chemistry and Laboratory Medicine, Kyushu Univ., Japan)

Naru Sato¹, Susumu Goyama¹, Xiaoxiao Liu¹, Takeshi Fujino¹, Taishi Yonezawa¹, Hitoshi Takizawa², Satoshi Yamasaki³, Tatsuhiro Shibata³, Toshio Kitamura¹ (1.Division of Cellular Therapy, IMS,Tokyo Univ., 2.IRCMS, Kumamoto Univ.,, 3.Laboratory of Molecular Medicine, Human Genome Center, IMS,Tokyo Univ.)

Yasutaka Hayashi¹, Susumu Goyama¹, Xiaoxiao Liu¹, Shiori Shikata¹, Yosuke Tanaka¹, Tomofusa Fukuyama¹, Akiko Matsumoto², Satoshi Yamasaki², Tatsuhiro Shibata², Hitoshi Takizawa³, Toshio Kitamura¹ (1.Cellular Therapy, IMSUT, Tokyo Univ., Tokyo, Japan, 2.Laboratory of Molecular Medicine, HGC, IMSUT, Tokyo Univ., Tokyo, Japan, 3.International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan)

Taishi Yonezawa¹, Hirotaka Takahashi², Shiori Shikata¹, Tomofusa Fukuyama¹, Yosuke Tanaka¹, Kenneth Kassenbrock³, Tatsuya Sawasaki², Toshio Kitamura¹, Susumu Goyama¹ (1.The institute of Medical Science, The University of Tokyo, Japan, 2.Proteo-Science Center (PROS)., Ehime University., Ehime, Japan, 3.Department of Pathlogy, The Univeresity of Colorado Anschutz Medical Campus)